The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy.
| Autor: | Blagosklonny, M V, Fojo, T, Bhalla, K N, Kim, J-S, Trepel, J B, Figg, W D, Rivera, Y, Neckers, L M |
|---|---|
| Zdroj: | Leukemia (08876924). Oct2001, Vol. 15 Issue 10, p1537-1543. 7p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|